| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 674127 | 96011001 | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CAELYX PEGYLATED LIPOSOMAL 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 2 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96011001/96011001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96011001/96011001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30180 | BAXTER S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 672136 | 08463001 | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE, 1 vial de 0,6 ml | 12 mg | 45 | 1 | 34 | 1 vial de 0,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08463001/08463001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08463001/08463001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30213 | ZENTIVA SPAIN S.L. | 2009-01-09 | 1 | 1 | 1 | 2009-01-09 | 2011-03-28 | 1 | 2012-03-22 | 662079 | View Edit Delete | |||||||||||
| 674741 | 72725 | RIASTAP 1 G POLVO PARA SOLUCION INYECTABLE O PERFUSION | RIASTAP 1 G POLVO PARA SOLUCION INYECTABLE O PERFUSION, 1 vial | 1.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72725/72725_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72725/72725_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-03-08 | 1 | 1 | 1 | 2011-03-08 | 2011-03-08 | 1 | 2012-05-03 | View Edit Delete | ||||||||||||
| 672240 | 72571 | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 20 viales de 25 mg | 25 mg | 45 | 20 | 34 | 20 viales de 25 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72571/72571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72571/72571_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44015 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2010-07-21 | 1 | 1 | 1 | 2010-07-21 | 2010-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 672241 | 72571 | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | LEVACT 2,5 mg/ml POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 5 viales de 100 mg | 100 mg | 45 | 5 | 34 | 5 viales de 100 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72571/72571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72571/72571_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44015 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 2010-07-21 | 1 | 1 | 1 | 2010-07-21 | 2010-07-21 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673954 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 15 ml | 1 mmol/ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 674119 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 30 ml | 1 mmol/ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 673037 | 06337011 | M-M-RVAXPRO POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE EN JERINGA PRECARGADA | M-M-RVAXPRO POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 vial + 1 jeringa precargada de disolvente | N/A (vacuna) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06337011/06337011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06337011/06337011_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2006-06-06 | 1 | 1 | 1 | 2006-06-06 | 2011-06-20 | 1 | 2011-10-05 | 654487, 663210 | View Edit Delete | |||||||||||
| 674275 | 61377 | ONCOTICE 2-8 X 10(8) UFC POLVO PARA SUSPENSION INTRAVESICAL | ONCOTICE 2-8 X 10(8) UFC POLVO PARA SUSPENSION INTRAVESICAL, 3 viales | N/A | 45 | 3 | 54 | 3 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61377/61377_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61377/61377_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 69623 | MERCK SHARP & DOHME DE ESPANA S.A. | 1997-06-01 | 1 | 1 | 1 | 1997-06-01 | 1997-06-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 673372 | 72609 | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 10 ml | 1 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72609/72609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72609/72609_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-08-11 | 1 | 1 | 1 | 2011-08-11 | 2011-08-11 | 1 | 2012-03-14 | View Edit Delete | ||||||||||||
| 673770 | 72386 | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 40 ml | 5 mg/ml inyectable 40 ml | 45 | 1 | 34 | 1 vial de 40 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72386/72386_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72386/72386_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2011-03-16 | 1 | 2011-06-20 | View Edit Delete | ||||||||||||
| 673413 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 4 ml | 20 mg/ml inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2011-01-10 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673414 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 7 ml | 20 mg/ml inyectable 7 ml | 45 | 1 | 34 | 1 vial de 7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2011-01-10 | 1 | 2011-07-26 | View Edit Delete | ||||||||||||
| 673420 | 72637 | IMIPENEM/CILASTATINA AUROVITAS 500 mg/500 mg POLVO PARA SOLUCION PARA PERFUSION EFG | IMIPENEM/CILASTATINA AUROVITAS 500 mg/500 mg POLVO PARA SOLUCION PARA PERFUSION EFG , 10 viales | 500 mg/500 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72637/72637_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72637/72637_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-02-02 | 1 | 1 | 1 | 2011-02-02 | 2011-02-02 | 1 | 2013-03-07 | View Edit Delete | ||||||||||||
| 672703 | 49313 | BLEOMICINA VIATRIS 15.000 UI (PH EUR) = 15 U (USP) POLVO PARA SOLUCION INYECTABLE | BLEOMICINA VIATRIS 15.000 UI (PH EUR) = 15 U (USP) POLVO PARA SOLUCION INYECTABLE, 1 vial | 15.000 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49313/49313_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49313/49313_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44524 | VIATRIS PHARMACEUTICALS S.L. | 1971-04-01 | 1 | 1 | 1 | 1971-04-01 | 2011-03-29 | 1 | 2011-06-28 | 719542, 754564, 656759 | View Edit Delete | |||||||||||
| 672096 | 51174 | COLIRCUSI GENTADEXA 5 MG/ML+ 1 MG/ML+ 0,5 MG/ML COLIRIO/GOTAS ÓTICAS EN SOLUCIÓN | COLIRCUSI GENTADEXA 5 MG/ML+ 1 MG/ML+ 0,5 MG/ML COLIRIO/GOTAS ÓTICAS EN SOLUCIÓN 1 frasco de 10 ml | 3 mg/ml + 1 mg/ml + 0,5 mg/ml | 56 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/51174/51174_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/51174/51174_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11601 | NTC OPHTHALMICS IBERICA SL | 1973-05-01 | 1 | 1 | 1 | 1973-05-01 | 2011-03-16 | 1 | 2011-10-17 | 695262, 653224 | View Edit Delete | |||||||||||
| 672095 | 22414 | COLIROFTA ANESTESICO 5 MG/ML + 0,5 MG/ML COLIRIO EN SOLUCION | COLIROFTA ANESTESICO 5 MG/ML + 0,5 MG/ML COLIRIO EN SOLUCION, 1 frasco de 10 ml | 0,5 mg/ml + 5 mg/ml | 56 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/22414/22414_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/22414/22414_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35498 | ALCON HEALTHCARE S.A. | 1954-12-01 | 1 | 1 | 1 | 1954-12-01 | 2011-03-16 | 1 | 2011-10-17 | 735159, 999804, 656486, 656837 | View Edit Delete | |||||||||||
| 672225 | 72544 | SATIVEX 2,7 MG/2,5 MG SOLUCION PARA PULVERIZACION BUCAL | SATIVEX 2,7 MG/2,5 MG SOLUCION PARA PULVERIZACION BUCAL , 3 envase de 10 ml | 2,7 mg/dosis + 2,5 mg/dosis | 68 | 30 | 26 | 3 envase de 10 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72544/72544_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72544/72544_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 67204 | ALMIRALL S.A. | 2010-07-16 | 1 | 1 | 1 | 2010-07-16 | 2010-07-16 | 1 | 2011-03-10 | Lista II | View Edit Delete | |||||||||||
| 673186 | 61451 | SEVORANE 100% LIQUIDO PARA INHALACION DEL VAPOR | SEVORANE 100% LIQUIDO PARA INHALACION DEL VAPOR , 1 frasco de 250 ml | 1 ml/ml | 71 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61451/61451_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61451/61451_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 1997-04-01 | 1 | 1 | 1 | 1997-04-01 | 1997-04-01 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 673016 | 62263 | NATECAL D 1.500 MG/400 UI COMPRIMIDOS MASTICABLES | NATECAL D 1.500 MG/400 UI COMPRIMIDOS MASTICABLES , 60 comprimidos | 1.500 mg (600 mg Ca)/400 UI | 72 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62263/62263_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62263/62263_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | ITALFARMACO S.A. | 1999-02-01 | 1 | 1 | 1 | 1999-02-01 | 2011-05-30 | 1 | 2011-07-11 | 656405 | View Edit Delete |
Page 268 of 1036, showing 20 records out of 20702 total, starting on record 5341, ending on 5360